Article
Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent manner.
Respiratory research - 20 May 2020
Kiss Edit, Abdelwahab El Husseiny Mohamed Mahmud, Steib Anita, Papp Emoke, Torok Zsofia, Jakab Laszlo, Smuk Gabor, Sarosi Veronika, Pongracz Judit Erzsebet
Abstract excerpt
BACKGROUND: The predominant metastatic site of lung cancer (LC) is the brain. Although outdated, conventional cisplatin treatment is still the main therapeutic approach for patients with advanced non-small cell lung cancer (NSCLC), since targeted therapy that offers better tumor control is not always possible. In the present study brain metastasis associated cytokine expression was investigated in primary NSCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.